Startup accelerator & VC Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Raidium healthtech, Medical Equipment Manufacturing | Other 13 Nov 2023 | | |
 | Artefact martech, Business Consulting and Services | Other 22 Nov 2023 | | |
 | STARTUP CREASPHERE powered by Plug and Play Venture Capital and Private Equity Principals | Other 2 Nov 2023 | | |
 | European Circular Bioeconomy Fund (ECBF) Financial Services | Other 1 Nov 2023 | | |
 | Supernova Invest Venture Capital and Private Equity Principals | Other 19 Oct 2023 | | |
 | AI for Health healthtech, IT Services and IT Consulting | Other 23 Oct 2023 | | |
 | European Pharmaceutical Manufacturer Book and Periodical Publishing | Other 27 Oct 2023 | | |
 | 2CFinance fintech, Financial Services | Other 24 Oct 2023 | | |
 | HEC Alumni entertainment, Civic and Social Organizations | Other 17 Oct 2023 | | |
 | Villa M - Paris healthtech | Other 18 Jan 2024 | | |